|
US7956064B2
(en)
*
|
2006-09-01 |
2011-06-07 |
Cylene Pharmaceuticals, Inc. |
Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
|
|
PL2268618T3
(pl)
|
2008-03-03 |
2015-11-30 |
Novartis Ag |
Związki i kompozycje jako modulatory aktywności receptorów TLR
|
|
US20100173013A1
(en)
*
|
2009-01-08 |
2010-07-08 |
Denis Drygin |
Treatment of neoplastic disorders using combination therapies
|
|
US20100267753A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Mustapha Haddach |
Methods of treating disorders associated with protein kinase ck2 activity
|
|
US9968574B2
(en)
*
|
2009-05-15 |
2018-05-15 |
The University Of Kentucky Research Foundation |
Treatment of MCI and Alzheimer's disease
|
|
IN2012DN02596A
(enExample)
*
|
2009-08-26 |
2015-08-28 |
Cylene Pharmaceuticals Inc |
|
|
DK2473510T3
(da)
*
|
2009-09-03 |
2014-10-20 |
Bristol Myers Squibb Co |
Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer
|
|
AU2010295622A1
(en)
*
|
2009-09-16 |
2012-05-10 |
Cylene Pharmaceuticals, Inc. |
Tricyclic compounds and pharmaceutical uses thereof
|
|
WO2011049625A1
(en)
|
2009-10-20 |
2011-04-28 |
Mansour Samadpour |
Method for aflatoxin screening of products
|
|
HRP20171537T1
(hr)
|
2009-11-05 |
2017-12-15 |
Rhizen Pharmaceuticals S.A. |
Novi modulatori benzopiran kinaze
|
|
US8853235B2
(en)
*
|
2009-11-23 |
2014-10-07 |
Senhwa Biosciences, Inc. |
Polymorphs and salts of a kinase inhibitor
|
|
HUE045270T2
(hu)
|
2010-01-05 |
2019-12-30 |
Inst Nat Sante Rech Med |
FLT3 receptor anatgonisták fájdalom rendellenességek kezelésére
|
|
US10106798B2
(en)
|
2010-01-05 |
2018-10-23 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
FLT3 receptor antagonists for the treatment or the prevention of pain disorders
|
|
TWI503323B
(zh)
|
2010-03-29 |
2015-10-11 |
Oncotherapy Science Inc |
三環化合物以及含此化合物之ｐｂｋ抑制劑
|
|
KR101992311B1
(ko)
|
2011-05-04 |
2019-09-27 |
리젠 파마슈티컬스 소시에떼 아노님 |
단백질 키나아제의 조절제로서 신규한 화합물
|
|
CN102731431A
(zh)
*
|
2012-06-20 |
2012-10-17 |
盛世泰科生物医药技术(苏州)有限公司 |
一种5-溴噻唑-4-甲酸的制备方法
|
|
LT2870157T
(lt)
|
2012-07-04 |
2017-12-11 |
Rhizen Pharmaceuticals S.A. |
Selektyvieji pi3k delta inhibitoriai
|
|
JP6437452B2
(ja)
|
2013-01-14 |
2018-12-12 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
|
|
LT2945939T
(lt)
|
2013-01-15 |
2020-07-27 |
Incyte Holdings Corporation |
Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai
|
|
CA2928568A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
EP3036238A1
(en)
|
2013-08-23 |
2016-06-29 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
US9540347B2
(en)
|
2015-05-29 |
2017-01-10 |
Incyte Corporation |
Pyridineamine compounds useful as Pim kinase inhibitors
|
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
CN108341774B
(zh)
*
|
2017-01-25 |
2022-07-19 |
首药控股(北京)股份有限公司 |
取代的喹啉酮类抑制剂
|
|
WO2019090205A1
(en)
|
2017-11-06 |
2019-05-09 |
Snap Bio, Inc. |
Pim kinase inhibitor compositions, methods, and uses thereof
|
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
|
ES2971712T3
(es)
|
2017-12-22 |
2024-06-06 |
Hibercell Inc |
Derivados de cromenopiridina como inhibidores de la fosfatidilinositol fosfato cinasa
|
|
US11071727B2
(en)
|
2018-01-26 |
2021-07-27 |
Northwestern University |
Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors
|
|
JP7143437B2
(ja)
*
|
2018-04-03 |
2022-09-28 |
碩英生醫股フン有限公司 |
Ｆｍｓ様チロシンキナーゼ阻害剤
|
|
WO2020100959A1
(ja)
*
|
2018-11-15 |
2020-05-22 |
日本新薬株式会社 |
１，３，４－オキサジアゾロン化合物及び医薬
|
|
CN109369526A
(zh)
*
|
2018-12-19 |
2019-02-22 |
桂林理工大学 |
一种两面针碱衍生物的合成方法及其抗肿瘤应用
|
|
GB201902759D0
(en)
|
2019-02-28 |
2019-04-17 |
Benevolentai Bio Ltd |
Compositions and uses thereof
|
|
TW202112784A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之𠳭唏并嘧啶衍生物
|
|
CN111320605A
(zh)
*
|
2020-03-09 |
2020-06-23 |
吉林工程技术师范学院 |
一种银催化的含氟菲啶衍生物的制备方法
|
|
CN113444085B
(zh)
*
|
2020-03-26 |
2022-04-08 |
东南大学 |
一种具有克服顺铂耐药的抗肿瘤化合物及其制备与应用
|
|
CN113444084A
(zh)
*
|
2020-03-26 |
2021-09-28 |
东南大学 |
一类抗肿瘤化合物及其制备与用途
|
|
KR20230004550A
(ko)
*
|
2020-03-30 |
2023-01-06 |
센화 바이오사이언시즈 인코포레이티드 |
간친화성 바이러스 감염증, 특히, 간염 b 및 간염 d를 치료하기 위한 항바이러스성 화합물 및 방법
|
|
EP3967307A1
(en)
|
2020-09-15 |
2022-03-16 |
Instytut Hematologii I Transfuzologii |
Use of pim kinase inhibitors to augment the efficacy of anti-cd20 antibody-based therapies in hematologic malignancies and non-malignant conditions
|
|
US20240025899A1
(en)
*
|
2020-10-16 |
2024-01-25 |
Shanghai De Novo Pharmatech Co., Ltd. |
Triheterocyclic derivative, and pharmaceutical composition and application thereof
|
|
GB202102895D0
(en)
*
|
2021-03-01 |
2021-04-14 |
Cambridge Entpr Ltd |
Novel compounds, compositions and therapeutic uses thereof
|
|
WO2023126951A1
(en)
*
|
2022-01-03 |
2023-07-06 |
Yeda Research And Development Co. Ltd. |
Inhibitors of autophagy-related protein-protein interactions
|
|
WO2023225586A2
(en)
*
|
2022-05-19 |
2023-11-23 |
4M Therapeutics Inc. |
Novel azaphenantrhene derivatives as inhibitors of glycogen synthase kinase 3 for therapeutic use
|
|
IL322451A
(en)
*
|
2023-02-03 |
2025-09-01 |
Mirati Therapeutics Inc |
Substituted tricyclic compounds
|
|
US11987581B1
(en)
|
2023-12-19 |
2024-05-21 |
King Faisal University |
Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-2-carboxylic acids as CK2 inhibitors
|
|
US12024518B1
(en)
|
2023-12-20 |
2024-07-02 |
King Faisal University |
Pyrazolo[4,3-C][1,6]naphthyridines as CK2 inhibitors
|
|
US12012414B1
(en)
|
2024-01-04 |
2024-06-18 |
King Faisal University |
Imidazo[1,5-a]pyrido[4,3-e]pyrimidines as CK2 inhibitors
|
|
US11964974B1
(en)
|
2024-01-08 |
2024-04-23 |
King Faisal University |
Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-3-carboxylic acids as CK2 inhibitors
|
|
US11981676B1
(en)
|
2024-01-16 |
2024-05-14 |
King Faisal University |
Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitors
|
|
US12187726B1
(en)
|
2024-02-06 |
2025-01-07 |
King Faisal University |
Imidazo[1,5-a]pyrido[4,3-e]pyrazines as CK2 inhibitors
|